# Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors

> **NCT00301782** · PHASE2 · COMPLETED · sponsor: **Medical Research Council** · enrollment: 88 (estimated)

## Conditions studied

- Extragonadal Germ Cell Tumor
- Teratoma
- Testicular Germ Cell Tumor

## Interventions

- **BIOLOGICAL:** bleomycin sulfate
- **DRUG:** carboplatin
- **DRUG:** cisplatin
- **DRUG:** etoposide phosphate
- **DRUG:** vincristine sulfate

## Key facts

- **NCT ID:** NCT00301782
- **Lead sponsor:** Medical Research Council
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2010-06
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2013-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00301782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00301782, "Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00301782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*